SCHEMBL9112778

SCHEMBL9112778

[CH2]C=C(C)n1c(=O)ccc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.49
CA9 Q16790 2/20 0.49
BRD4 O60885 1/20 0.49
BRPF1 P55201 1/20 0.49
KAT2B Q92831 1/20 0.49
BRD9 Q9H8M2 1/20 0.49
NOTUM Q6P988 1/20 0.39
KMT2A Q03164 4/20 0.37
POLB P06746 1/20 0.34
MAPK1 P28482 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
DAO P14920 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.30
TSHR P16473 1/20 0.30
RAB9A P51151 1/20 0.30
PRKD3 O94806 1/20 0.30
PRKCG P05129 1/20 0.30
PRKCB P05771 1/20 0.30
PRKCA P17252 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568800 0.79 CA12 (0.55) CA12CA9BRD4BRPF1KAT2B
SCHEMBL30672091 0.79 CA12 (0.55) CA12CA9BRD4BRPF1KAT2B
SCHEMBL10662835 0.74 CA12 (0.53) CA12CA9BRD4BRPF1KAT2B
SCHEMBL6581393 0.73 CA12 (0.52) CA12CA9BRD4BRPF1KAT2B
SCHEMBL30321500 0.71 CA12 (0.50) CA12CA9BRD4BRPF1KAT2B
SCHEMBL30804587 0.70 RAB9A (0.56) CA12CA9BRD4BRPF1KAT2B
SCHEMBL6195893 0.70 RAB9A (0.56) CA12CA9BRD4BRPF1KAT2B
SCHEMBL29018547 0.69 CA12 (0.44) CA12CA9BRD4BRPF1KAT2B
SCHEMBL7957507 0.69 CA12 (0.47) CA12CA9BRD4BRPF1KAT2B
SCHEMBL5722231 0.69 ADORA3 (0.48) CA12CA9BRD4BRPF1KAT2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed